Abstract
Jun dimerization protein 2 (JDP2) forms a dimeric complex that can include members of the Jun, Fos, ATF-2, Maf and other families of AP-1 proteins. JDP2 acts as a repressor that binds to the AP-1 site in promoters and is a possible tumor-suppressor. We describe here how the transactivation of the c-Jun gene by p300 and ATF-2 involves recruitment of the histone deacetylase complex (HDAC3), with repression of retinoic acid-induced (RA-induced) transcription of the c- Jun gene and subsequent inhibition of the RA-mediated differentiation of F9 cells. We summarize that JDP2 has activities associated with histone binding and inhibition of histone acetyltransferases (INHAT), as well as with the regulation of chromatin assembly. These observations indicate that JDP2 not only acts as a sequence-specific DNA-binding protein but also controls the transcription of AP-1-responsive genes by direct regulation of histone modification. We discuss here a new perspective on the role of JDP2 in the chromatin-related mechanism that regulates the transcription of genes that are the targets of AP-1 proteins.
Keywords: histone acetyltransferases, ap proteins, dna-binding protein, cyclic amp response element, oncogenic, tumorigenesis, chip assays, transformation
Current Genomics
Title: Jun Dimerization Protein 2: A Multifunctional Transcription Factor in Mammalian Cells
Volume: 6 Issue: 5
Author(s): T. Yamasaki, M. Noguchi, B. Liu, K. Nakade, P- C. Wang, T. Murata and K. K. Yokoyama
Affiliation:
Keywords: histone acetyltransferases, ap proteins, dna-binding protein, cyclic amp response element, oncogenic, tumorigenesis, chip assays, transformation
Abstract: Jun dimerization protein 2 (JDP2) forms a dimeric complex that can include members of the Jun, Fos, ATF-2, Maf and other families of AP-1 proteins. JDP2 acts as a repressor that binds to the AP-1 site in promoters and is a possible tumor-suppressor. We describe here how the transactivation of the c-Jun gene by p300 and ATF-2 involves recruitment of the histone deacetylase complex (HDAC3), with repression of retinoic acid-induced (RA-induced) transcription of the c- Jun gene and subsequent inhibition of the RA-mediated differentiation of F9 cells. We summarize that JDP2 has activities associated with histone binding and inhibition of histone acetyltransferases (INHAT), as well as with the regulation of chromatin assembly. These observations indicate that JDP2 not only acts as a sequence-specific DNA-binding protein but also controls the transcription of AP-1-responsive genes by direct regulation of histone modification. We discuss here a new perspective on the role of JDP2 in the chromatin-related mechanism that regulates the transcription of genes that are the targets of AP-1 proteins.
Export Options
About this article
Cite this article as:
Yamasaki T., Noguchi M., Liu B., Nakade K., Wang C. P-, Murata T. and Yokoyama K. K., Jun Dimerization Protein 2: A Multifunctional Transcription Factor in Mammalian Cells, Current Genomics 2005; 6 (5) . https://dx.doi.org/10.2174/1389202054750194
DOI https://dx.doi.org/10.2174/1389202054750194 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Dual Roles of Sulforaphane in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Alzheimer’s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Current Pharmaceutical Design Recent Developments in the Synthesis and Biological Activity of Muramylpeptides
Current Medicinal Chemistry Rho GTPases: Promising Cellular Targets for Novel Anticancer Drugs
Current Cancer Drug Targets Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
Current Genomics The Relationship between Pharmacological Properties and Structure- Activity of Chrysin Derivatives
Mini-Reviews in Medicinal Chemistry Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Current Pharmaceutical Design Neurophysiological Mechanisms Related to Pain Management in Bone Tumors
Current Neuropharmacology Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Decreased lncRNA SNHG16 Accelerates Oxidative Stress Induced Pathological Angiogenesis in Human Retinal Microvascular Endothelial Cells by Regulating miR-195/mfn2 Axis
Current Pharmaceutical Design The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV?
Current HIV Research High-Content Analysis of Kinase Activity in Cells
Combinatorial Chemistry & High Throughput Screening Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery Microtubule-targeting Anticancer Agents from Marine Natural Substance
Anti-Cancer Agents in Medicinal Chemistry The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: A Review
Recent Patents on Anti-Cancer Drug Discovery Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued) Emulsomes Meet S-layer Proteins: An Emerging Targeted Drug Delivery System
Current Pharmaceutical Biotechnology Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets